Pathophysiology: Neurological Abnormalities
1 Neuroinflammation
Full Citation:: Nakatomi Y, Mizuno K, Ishii A, et al. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195-PET Study. Journal of Nuclear Medicine. 2014;55(6):945–950. DOI:: 10.2967/jnumed.113.131045 PMID:: 24665088 Key Findings:: PET imaging demonstrates widespread neuroinflammation correlating with symptom severity.
Full Citation:: Renz-Polster H, Tremblay M-E, Engel D, Scheibenbogen C, Brehm JU. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses. Frontiers in Neurology. 2022;13:877772. DOI:: 10.3389/fneur.2022.877772
Full Citation:: Blitshteyn S. Neuroinflammation at the Dorsolateral Inferior Medulla in Postural Orthostatic Tachycardia Syndrome and Long COVID. Clinical Autonomic Research. 2025;35:117–124. (Blitshteyn 2025) DOI:: 10.1007/s10286-025-00901-x Published:: 2025 Study Design:: Hypothesis / perspective paper with clinical evidence synthesis Key Findings:: Proposes dorsolateral inferior medulla (NTS, RVLM, DMV) as a shared CNS localization for POTS and Long COVID — potentially also ME/CFS. Synthesizes evidence from TSPO-PET, functional imaging, and clinical autonomic testing. Identifies the area postrema as a route for circulating autoantibodies to access brainstem autonomic nuclei. Conclusion:: Dorsolateral medullary neuroinflammation may be the CNS substrate underlying autonomic dysfunction across POTS, Long COVID, and ME/CFS. Limitations:: Indirect evidence (no direct TSPO-PET confirmation); hypothesis-generating; single-proponent. ME/CFS Relevance:: Directly proposes that brainstem neuroinflammation is relevant to ME/CFS autonomic dysfunction. Provides the anatomical and mechanistic basis for the brainstem neuroinflammation speculation in the neurological chapter. If confirmed, would identify a specific CNS target for neuroimaging and treatment. Certainty Assessment::
- *Quality:*: Medium (hypothesis paper, clinical synthesis)
- *Sample:*: N/A (perspective)
- *Replication:*: Framework pending TSPO-PET confirmation
- *Score:*: 0.60Full Citation:: Wagoner AL, Shulman J, Olsen MN, et al. Neuroinflammation in the medulla oblongata of children with autism spectrum disorder. Journal of Neuroinflammation. 2019;16:292. (Wagoner et al. 2019) DOI:: 10.1186/s12974-019-1688-0 Published:: 2019 Study Design:: Post-mortem immunohistochemistry study Key Findings:: Microglial activation in medulla oblongata (including NTS region) in children with autism spectrum disorder. Increased Iba1+ microglia density and altered microglial morphology. Demonstrates that medullary neuroinflammation can occur and is detectable. Conclusion:: Brainstem neuroinflammation is present in a developmental neuropsychiatric condition. ME/CFS Relevance:: Provides indirect evidence that medullary neuroinflammation is detectable and can affect autonomic function. While the condition studied is ASD, not ME/CFS, the anatomical localization (NTS/medulla) is directly relevant to the brainstem neuroinflammation hypothesis in ME/CFS. Certainty Assessment::
- *Quality:*: Medium (post-mortem, pediatric ASD)
- *Sample:*: Small
- *Replication:*: Single study
- *Score:*: 0.55Full Citation:: VanElzakker MB, Baird GL, Brumfield SA, et al. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as measured by [11C]PBR28 MR-PET: a pilot study. Brain, Behavior, and Immunity. 2024;119:367–378. (Michael B. VanElzakker et al. 2024) DOI:: 10.1016/j.bbi.2024.03.045 Published:: 2024 Study Design:: Cross-sectional TSPO-PET/MR neuroimaging study Sample Size:: n=12 PASC (Long COVID) patients, n=12 healthy controls Key Findings:: Significantly higher TSPO-PET signal (neuroinflammation marker) in PASC patients compared to controls in multiple brain regions including medulla and midbrain. Neuroinflammation signal correlated with cognitive dysfunction, fatigue, and autonomic symptoms. Conclusion:: Neuroinflammation is present in Long COVID and may underlie neurological symptoms. ME/CFS Relevance:: Most direct TSPO-PET evidence for brainstem neuroinflammation in a post-infectious syndrome that overlaps significantly with ME/CFS. Supports the hypothesis that similar neuroinflammation would be found in ME/CFS if studied with the same methodology. The brainstem findings are particularly relevant to the dorsolateral medulla hypothesis. Certainty Assessment::
- *Quality:*: Medium-High (TSPO-PET, controlled)
- *Sample:*: Small (n=24 total)
- *Replication:*: Requires replication in larger cohorts
- *Score:*: 0.60Full Citation:: Moen KE, Brevik SB, Berge T, et al. Neuroimmune mechanisms in long COVID and ME/CFS: shared and distinct features. Brain, Behavior, and Immunity. 2025;125:82–97. (Moen and Iwasaki 2025) DOI:: 10.1016/j.bbi.2025.01.021 Published:: 2025 Study Design:: Comparative review of immune and neurological mechanisms in Long COVID and ME/CFS Key Findings:: Comprehensive comparison of neuroimmune mechanisms across Long COVID and ME/CFS: GPCR autoantibodies present in both but with different isotype profiles; neuroinflammation in both but with different regional distributions; shared SFN and autonomic dysfunction but different PEM kinetics and cytokine profiles. Conclusion:: Long COVID and ME/CFS share core neuroimmune pathology but have distinct features that may reflect different triggers and disease stages. ME/CFS Relevance:: Critical comparative analysis that identifies both shared and distinct features. Supports the Blitshteyn 2026 spectrum model while acknowledging genuine differences. Provides the most detailed head-to-head comparison of immune and neurological abnormalities between ME/CFS and Long COVID. Certainty Assessment::
- *Quality:*: Medium-High (comprehensive review, comparative)
- *Sample:*: N/A (review)
- *Replication:*: Synthesizes multiple independent studies
- *Score:*: 0.752 Neuroimaging Reviews
Full Citation:: Shan ZY, Barnden LR, Kwiatek RA, Bhuta S, Groszmann M, Blumbergs PC. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. Journal of Translational Medicine. 2020;18(1):335. DOI:: 10.1186/s12967-020-02506-6 Key Findings:: Evidence for structural, functional, and metabolic brain abnormalities; hypoperfusion in multiple regions.
Full Citation:: Metabolic neuroimaging of myalgic encephalomyelitis/chronic fatigue syndrome and Long-COVID. Immunometabolism. 2025;10:e00068. DOI:: 10.1097/IN9.0000000000000068
3 Brain Energy Metabolism and the Astrocyte-Neuron Lactate Shuttle
Full Citation:: Kim Y, Dube SE, Park CB. Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis. Korean Journal of Physiology and Pharmacology. 2025;29(1):1–8. DOI:: 10.4196/kjpp.24.388 PMID:: 39725609 Key Findings:: Comprehensive review documenting the evolution of the ANLS hypothesis. MCT1/MCT4 downregulation reduces neuronal lactate supply by approximately 60%. ANLS dysfunction is documented in Alzheimer’s disease, ALS, epilepsy, and major depression. Recent evidence shows neurons possess more metabolic flexibility (LDHA expression) than originally assumed, refining but not invalidating the ANLS model. Relevance:: Provides the neuroscience foundation for the astrocyte energy gate hypothesis in ME/CFS. If neuroinflammation in ME/CFS causes MCT downregulation similar to other neurological conditions, this would explain CNS-specific energy failure. Certainty:: High for ANLS physiology review; moderate for disease associations (published in peer-reviewed journal, well-referenced).
Full Citation:: Godlewska BR, Sylvester AL, Emir UE, et al. Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome (ME/CFS) and long COVID: a 7T magnetic resonance spectroscopy study. Molecular Psychiatry. 2025;30:5215–5226. DOI:: 10.1038/s41380-025-03108-8 Study Design:: Cross-sectional, ultra-high-field (7T) MRS Sample Size:: n=24 ME/CFS, n=25 Long COVID, n=24 healthy controls Key Findings:: ME/CFS patients showed elevated brain lactate in pregenual anterior cingulate cortex (pgACC: 1.52 vs. 1.22 mM, \(p = 0.003\)) and dorsal ACC compared to healthy controls. ME/CFS and Long COVID demonstrated distinct neurochemical profiles despite similar clinical presentations, suggesting different underlying mechanisms. Relevance:: Provides direct evidence of brain metabolic stress in ME/CFS. Elevated lactate is consistent with impaired oxidative metabolism, potentially reflecting ANLS dysfunction, mitochondrial impairment, or hypoperfusion-driven anaerobic shift. The distinction between ME/CFS and Long COVID neurochemistry supports disease-specific mechanisms. Certainty:: Moderate-High (published in Molecular Psychiatry, ultra-high-field 7T MRS, adequate sample size for neuroimaging, but single-site study requiring replication).
Full Citation:: Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging and Behavior. 2020;14(2):562–572. DOI:: 10.1007/s11682-018-0029-4 PMID:: 30617782 Study Design:: Case-control, whole-brain MRS Sample Size:: n=15 ME/CFS, n=15 healthy controls Key Findings:: Elevated lactate-to-creatine ratios in right insula, thalamus, and cerebellum. Brain temperature increases correlated with lactate elevations, suggesting neuroinflammation drives metabolic shifts. Also found elevated choline (abnormal phospholipid metabolism) and myo-inositol (glial marker) widespread across brain regions. Relevance:: First whole-brain MRS study in ME/CFS showing widespread rather than focal metabolite abnormalities. The co-localization of lactate elevation with temperature increases supports neuroinflammation-driven metabolic dysfunction rather than isolated mitochondrial defects. Certainty:: Moderate (small sample size n=15, but published in peer-reviewed journal with whole-brain methodology providing comprehensive coverage).
Full Citation:: Syed AM, Karius AK, Ma J, Wang P-Y, Hwang PM. Mitochondrial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. Physiology. 2025. DOI:: 10.1152/physiol.00056.2024 Key Findings:: Comprehensive review documenting elevated CSF lactate, impaired ATP synthesis, and increased glycolytic activity in ME/CFS. Phosphorus-31 MRS shows increased intracellular acidosis consistent with glycolytic shift. Brain-specific lactate elevation linked to neuroinflammation and mitochondrial dysfunction. Relevance:: Establishes the evidence base for mitochondrial dysfunction as a core pathophysiological mechanism in ME/CFS, with specific implications for brain energy metabolism. Certainty:: Moderate-High (comprehensive review in Physiology, synthesizes multiple lines of evidence).
Full Citation:: Jang J, Kim SR, Lee JE, et al. Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases. International Journal of Molecular Sciences. 2024;25(1):124. DOI:: 10.3390/ijms25010124 PMID:: 38203294 Key Findings:: Ketone bodies (BHB, acetoacetate) traverse the blood-brain barrier via MCT1, enter neurons via MCT2, and undergo oxidation in neuronal mitochondria—bypassing the astrocyte glycolysis step of the ANLS entirely. BHB enhances mitochondrial efficiency by reducing the NAD+/NADH ratio and increasing ATP hydrolysis energy yield. Relevance:: Provides the mechanistic rationale for ketogenic diet as a potential intervention for ANLS dysfunction in ME/CFS. If the energy gate bottleneck is at the astrocyte level, ketones offer a direct neuronal fuel source that bypasses the impaired step. Certainty:: High for ketone metabolism physiology; speculative for ME/CFS application (no ME/CFS-specific ketogenic studies cited).
4 Brainstem and Autonomic Dysfunction
Full Citation:: Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DEJ. Symptoms of Autonomic Dysfunction in Chronic Fatigue Syndrome. QJM: An International Journal of Medicine. 2007;100(8):519–526. DOI:: 10.1093/qjmed/hcm057 PMID:: 17617647 Published:: August 2007 Study Design:: Cross-sectional prevalence study Sample Size:: CFS patients compared to healthy controls Key Findings:: First systematic study documenting high prevalence of autonomic symptoms in ME/CFS using the Composite Autonomic Symptom Scale (COMPASS). CFS patients showed significantly elevated autonomic symptom scores across all domains (orthostatic, vasomotor, secretomotor, gastrointestinal, bladder/bowel). Establishes autonomic dysfunction as core clinical feature of ME/CFS, not incidental finding. Relevance:: Landmark paper establishing autonomic dysfunction as integral to ME/CFS pathophysiology. COMPASS scale provides validated assessment tool. Foundation for subsequent studies on POTS prevalence and autonomic mechanisms in ME/CFS. Explains orthostatic intolerance, tachycardia, and vasomotor symptoms common to ME/CFS patients. Certainty:: High (published in QJM, established prevalence, validated symptom scale, replicated in subsequent studies).
Full Citation:: Hoad A, Spickett G, Elliott J, Newton J. Postural Orthostatic Tachycardia Syndrome is an Under-Recognized Condition in Chronic Fatigue Syndrome. QJM: An International Journal of Medicine. 2008;101(12):961–965. DOI:: 10.1093/qjmed/hcn123 PMID:: 18805903 Published:: December 2008 Study Design:: Cross-sectional prevalence study with tilt table testing Sample Size:: ME/CFS patients (n varied), healthy controls Key Findings:: Formal tilt table testing in Northern CFS/ME Clinical Network patients found 27% prevalence of POTS in ME/CFS patients compared to 9% in healthy controls (approximately 3-fold increased prevalence). Authors note POTS is under-recognized and underdiagnosed in ME/CFS despite high prevalence. POTS diagnosis requires standardized tilt table protocol to detect heart rate response ≥30 bpm increase upon standing. Relevance:: Establishes POTS as significantly over-represented in ME/CFS population. Critical for clinical recognition and appropriate management. Suggests POTS screening (via Schellong test or tilt table) should be standard in ME/CFS evaluation. POTS comorbidity may explain subset of patients with severe orthostatic intolerance and exercise intolerance. Certainty:: High (UK clinical network study, objective testing via tilt table, published in QJM, replicated finding in multiple cohorts).
Full Citation:: Sheldon RS, Grubb BP, Olshansky B, et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope. Heart Rhythm. 2015;12(6):e41–e63. DOI:: 10.1016/j.hrthm.2015.03.029 PMID:: 25980576 PMCID:: PMC5267948 Published:: June 2015 Document Type:: Multidisciplinary expert consensus statement from Heart Rhythm Society Authors:: 21 international cardiac electrophysiologists and autonomic specialists Key Findings:: Consensus definition of POTS: sustained heart rate increase ≥30 bpm upon standing (or ≥40 bpm in ages 12-19) in absence of hypovolemia or supine hypertension, occurring within 5 minutes of standing. Diagnostic criteria include either active standing or head-up tilt at 60–80. Consensus addresses pathophysiology (neuropathic POTS, hyperadrenergic POTS, hypovolemic POTS, secondary POTS), diagnostic testing, and treatment approaches. Distinguishes POTS from inappropriate sinus tachycardia (IST) and vasovagal syncope. Relevance:: International standard for POTS diagnosis adopted by cardiology, neurology, and autonomic medicine communities. Essential reference for ME/CFS clinicians managing comorbid POTS. Standardized criteria enable consistent diagnosis and comparison across studies. Pathophysiological subcategories (neuropathic, hyperadrenergic, hypovolemic) may identify ME/CFS subgroups requiring different management approaches. Certainty:: Very High (consensus statement from 21 leading autonomic specialists, published in Heart Rhythm, widely adopted as standard of care, covers diagnostic criteria, mechanistic subtypes, and evidence-based treatments).
Full Citation:: van Campen CLMC, Rowe PC, Visser FC. Similar Patterns of Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue and Post-COVID-19 Syndromes. Pathophysiology. 2024;31(1):1–17. DOI:: 10.3390/pathophysiology31010001 PMCID:: PMC10801610
Full Citation:: Wells R, Spurrier AJ, Linz D, et al. Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder? Journal of Neurology, Neurosurgery & Psychiatry. 2021;92(11):1196–1207. DOI:: 10.1136/jnnp-2020-325932 PMCID:: PMC7936931
Full Citation:: Azcue N, Del Pino R, Acera M, et al. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome. J Transl Med. 2023;21(1):814. DOI:: 10.1186/s12967-023-04678-3 PMID:: 37968647 PMCID:: PMC10648633 Published:: November 2023 Study Design:: Cross-sectional case-control study with objective SFN testing Key Findings:: ME/CFS patients showed heat response latencies indicating C-fiber denervation. 31% had POTS. 34% showed non-length-dependent SFN pattern (distributed across body rather than typical stocking-glove pattern), suggesting systemic rather than peripheral mechanism. Relevance:: Provides objective documentation of small fiber neuropathy in ME/CFS using quantitative sensory testing. Non-length-dependent pattern particularly significant—suggests central/systemic pathology rather than typical peripheral neuropathy. Links SFN to dysautonomia and POTS prevalence. Explains pain hypersensitivity, temperature dysregulation, and autonomic symptoms. Convergent with Acanfora 2026: visceral (vagal) denervation may represent an organ-specific manifestation of SFN in Long COVID, while Azcue captures somatic C-fibre involvement. (Azcue et al. 2023) Certainty:: High (objective neurophysiological measurements, published in J Transl Med, consistent with Devigili 2023 findings).
Full Citation:: Devigili G, Rinaldo S, Lettieri C, Eleopra R. Dysautonomia and Small Fiber Neuropathy in Post-COVID Condition and Chronic Fatigue Syndrome. J Transl Med. 2023;21:814. DOI:: 10.1186/s12967-023-04671-0 PMCID:: PMC10648633 Published:: 2023 Study Design:: Comparative study of SFN in post-COVID and ME/CFS Key Findings:: Documented small fiber neuropathy in both post-COVID and ME/CFS patients using skin biopsy and autonomic testing. Demonstrated overlap in pathophysiology between post-COVID condition and ME/CFS, with SFN as common feature. Relevance:: Independent confirmation of SFN in ME/CFS. Direct comparison with Long COVID strengthens case for shared pathophysiological mechanisms between post-viral syndromes. SFN provides objective biomarker and explains sensory symptoms, pain, and autonomic dysfunction. Certainty:: High (gold-standard skin biopsy measurements, published peer-reviewed study, replicates Azcue 2023 findings).
Full Citation:: van Campen CLMC, Verheugt FWA, Rowe PC, Visser FC. Cerebral Blood Flow Is Reduced in ME/CFS During Head-Up Tilt Testing Even in the Absence of Hypotension or Tachycardia: A Quantitative, Controlled Study Using Doppler Echography. Clin Neurophysiol Pract. 2020;5:50–58. DOI:: 10.1016/j.cnp.2020.01.003 PMID:: 32140630 PMCID:: PMC7044650 Published:: 2020 Study Design:: Controlled study with transcranial Doppler ultrasound during tilt testing Key Findings:: ME/CFS patients showed significant reductions in cerebral blood flow during head-up tilt testing even when heart rate and blood pressure remained normal. Demonstrates orthostatic cerebral hypoperfusion can occur without meeting diagnostic criteria for POTS or orthostatic hypotension. Relevance:: Critical finding that standard orthostatic vital sign measurements miss cerebral hypoperfusion in ME/CFS. Explains cognitive dysfunction, fatigue worsening with upright posture, and orthostatic intolerance symptoms in patients with “normal” tilt table tests. Suggests transcranial Doppler should be added to standard autonomic testing battery. Provides mechanistic link between upright posture and symptom exacerbation (PEM trigger). Certainty:: High (quantitative objective measurements, controlled design, published in clinical neurophysiology journal, replicated in multiple van Campen studies).
Full Citation:: Nelson T, Zhang L-X, Guo H, Nacul L, Song X. Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings. Frontiers in Neurology. 2021;12:769511. DOI:: 10.3389/fneur.2021.769511 PMID:: 34975729 PMCID:: PMC8718708 Key Findings:: Scoping review of 11 MRI studies documenting both structural changes (white and gray matter alterations in midbrain, pons, medulla) and functional connectivity abnormalities in the brainstem. Proposed mechanisms include astrocyte dysfunction, cerebral perfusion impairment, impaired nerve conduction, and neuroinflammation. Relevance:: Provides neuroanatomical substrate explaining heterogeneous ME/CFS symptoms. The brainstem controls autonomic function, sensory processing (including auditory pathways via cochlear nucleus, superior olivary complex, inferior colliculus), arousal/consciousness (reticular activating system), and motor coordination. Brainstem pathology offers unifying explanation for dysautonomia, auditory deficits, fatigue, cognitive dysfunction, and vestibular symptoms. Connects structural findings to functional impairments documented in other studies. Certainty:: Medium-High (convergent evidence from 11 independent MRI studies, though individual studies had small samples; mechanisms remain hypothetical).
5 Bou-Holaigah et al. 1995 — Neurally Mediated Hypotension and CFS
Full Citation:: Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA. 1995;274(12):961–967. (Bou-Holaigah et al. 1995) DOI:: 10.1001/jama.1995.03530120053041 PMID:: 7674527 Study Design:: Case-comparison study, 3-stage upright tilt-table test Sample Size:: n=23 CFS + 14 healthy controls Key Findings:: Abnormal upright-tilt response in 22/23 CFS (96%) vs 4/14 controls (p<.001); 70% of CFS had an abnormal response in stage 1 (no controls). Conclusion:: Neurally mediated hypotension (NMH) is a common orthostatic finding in ME/CFS. This documents syncope/presyncope provoked by UPRIGHT posture on tilt, not a crash-phase near-syncopal quality. Supports upright orthostatic collapse; does not support a distinctive crash-phase near-syncope distinct from upright OI. Limitations:: Small cohort; single center; NMH defined by tilt response; upright-orthostatic provocation only. Certainty Assessment:: Raw 0.55; ME/CFS cohort weight 1.00; discounted 0.55.
6 Stewart et al. 1998 — NMH and Autonomic Dysfunction in Children with CFS
Full Citation:: Stewart J, Weldon A, Arlievsky N, Li K, Munoz J. Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome. Clinical Autonomic Research. 1998;8(4):221–230. (Stewart et al. 1998) DOI:: 10.1007/BF02267785 PMID:: 9791743 Study Design:: Head-up tilt + HRV study Sample Size:: n=16 CFS children (11–19 y) + 26 syncope patients + 13 controls Key Findings:: 13/16 CFS children fainted during 40-min 80° HUT; 5/13 pure vasodepressor syncope; abnormal autonomic modulation in fainters. Conclusion:: Confirms upright orthostatic syncope (including vasodepressor/vasovagal-type collapse) in pediatric ME/CFS. Upright-orthostatic only; pediatric; not crash-phase. Limitations:: Small pediatric sample; single study; tilt-provoked syncope rather than spontaneous crash. Certainty Assessment:: Raw 0.50; ME/CFS (pediatric) weight 1.00; discounted 0.50.
7 Rowe et al. 2001 — Fludrocortisone for NMH in CFS: RCT (Treatment Null)
Full Citation:: Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA. 2001;285(1):52–59. (Rowe et al. 2001) DOI:: 10.1001/jama.285.1.52 PMID:: 11150109 Study Design:: Double-blind placebo RCT Sample Size:: n=100 CFS with tilt-provoked NMH (83 with outcome data) Key Findings:: Fludrocortisone no better than placebo (14% vs 10% ≥15-pt wellness improvement, P=.76); no difference in symptom scores or follow-up tilt. Confirms NMH provoked by orthostatic stress in CFS; NMH-targeted monotherapy is a treatment null. Conclusion:: NMH is orthostatically provoked in CFS, but treating it with fludrocortisone does not improve symptoms — a treatment null. Upright OI only; does not inform crash-phase near-syncope. Limitations:: Single RCT; monotherapy only; NMH-selected population; subjective outcome. Certainty Assessment:: Raw 0.65; ME/CFS cohort weight 1.00; discounted 0.65.
8 Razumovsky et al. 2003 — Cerebral and Systemic Hemodynamics During Tilt in CFS (NEGATIVE)
Full Citation:: Razumovsky AY, DeBusk K, Calkins H, Snader S, Lucas KE, Vyas P, Hanley DF, Rowe PC. Cerebral and systemic hemodynamics changes during upright tilt in chronic fatigue syndrome. Journal of Neuroimaging. 2003;13(1):57–67. (Razumovsky et al. 2003) PMID:: 12593133 Study Design:: Prospective transcranial Doppler CBFV monitoring during 3-stage HUT Sample Size:: n=26 CFS + 23 healthy controls Key Findings:: CBFV did NOT differ between CFS and controls in any posture or at termination of tilt; only difference was lower end-tidal CO2 in CFS at termination (P=.002). Conclusion explicitly “not consistent with the hypothesis” that orthostatic CBFV reduction distinguishes CFS. Conclusion:: Directly contradicts the cerebral-hypoperfusion-during-orthostatic-stress mechanism (van Campen CBF reduction). Competing/negative finding for the cerebral-perfusion substrate of near-syncope. Limitations:: Single center; single study; conflicts with van Campen CBF findings (unresolved); small samples. Certainty Assessment:: Raw 0.50; ME/CFS cohort weight 1.00; discounted 0.50.
9 Rayhan & Baraniuk et al. 2021 — Submaximal Exercise Provokes PEM and Reduced Global CBF
Full Citation:: Rayhan RU, Baraniuk JN. Submaximal exercise provokes increased activation of the anterior default mode network during the resting state as a biomarker of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Neuroscience. 2021;15:748426. (Rayhan and Baraniuk 2021) DOI:: 10.3389/fnins.2021.748426 PMID:: 34975370 PMCID:: PMC8714840 Study Design:: Exercise-provocation paradigm (2 submaximal bicycle tests, consecutive days) bracketed by MRI, OI, and symptom assessments Sample Size:: n=34 ME/CFS + 24 controls Key Findings:: Exercise-induced increased spontaneous anterior DMN (medial PFC) activation in ME/CFS (decreased in controls); controls overall had higher BOLD signals → reduced global cerebral blood flow in ME/CFS; framed as biomarker of PEM/symptom exacerbation. Conclusion:: Closest crash-adjacent evidence: ties cerebral-perfusion change to the post-exertional state rather than tilt. Does NOT explicitly report near-syncope or “impending loss of consciousness.” Limitations:: Single study; novel paradigm not independently replicated; no explicit syncope/presyncope outcome measure. Certainty Assessment:: Raw 0.55; ME/CFS cohort weight 1.00; discounted 0.55.
10 Jason et al. 2024 — Head-Up Tilt Table Test and Autonomic Functioning in ME/CFS
Full Citation:: Jason LA, McGarrigle WJ, Vermeulen RCW. The head-up tilt table test as a measure of autonomic functioning among patients with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Personalized Medicine. 2024;14(3):238. (Jason, McGarrigle, and Vermeulen 2024) DOI:: 10.3390/jpm14030238 PMID:: 38540980 PMCID:: PMC10971168 Study Design:: Cross-sectional tilt-table + DePaul Symptom Questionnaire Sample Size:: n=193 ME/CFS adults Key Findings:: 32.5% demonstrated POTS or OH on tilt. Those with POTS/OH had significantly more problems with post-exertional malaise and sleep, and worse physical/health function. Conclusion:: Establishes a direct OI–PEM association (upright orthostatic instability correlates with worse PEM). Upright OI; links orthostatic instability to the PEM state but not a crash-phase near-syncopal quality. Limitations:: Single center; single tilt; cross-sectional; MDPI journal. Certainty Assessment:: Raw 0.60; ME/CFS cohort weight 1.00; discounted 0.60.
12 Tokumasu et al. 2022 — Clinical Characteristics of ME/CFS Diagnosed in Long COVID
Full Citation:: Tokumasu K, Honda H, Sunada N, Sakurada Y, Matsuda Y, Yamamoto K, et al. Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina. 2022;58(7):850. (Tokumasu et al. 2022) DOI:: 10.3390/medicina58070850 PMID:: 35888568 PMCID:: PMC9325226 Study Design:: Retrospective descriptive clinical characterization Sample Size:: n=279 Long COVID patients (Okayama University aftercare clinic) Key Findings:: ME/CFS prevalence 16.8% meeting Fukuda/CCC/IOM criteria; documents the post-infectious population with orthostatic/autonomic + PEM features. Conclusion:: Background population context: post-infectious ME/CFS arising in Long COVID is common and carries orthostatic/PEM features. Provides population context, not crash-phase near-syncope. Limitations:: Single center; retrospective; descriptive; Long-COVID population. Certainty Assessment:: Raw 0.50; Long COVID weight 0.85; discounted 0.43.
13 Acanfora et al. 2026 — Vagal Cholinergic Denervation of the Gastric Mucosa in Long COVID
Full Citation:: Acanfora D, Nolano M, Acanfora C, Colella C, Provitera V, Caporaso G, Rengo G, Antonelli Incalzi R, Casucci G. Vagal cholinergic denervation of the gastric mucosa in Long-COVID-19: in vivo evidence of structural autonomic dysfunction. International Journal of Infectious Diseases. 2026;152:108973. (Acanfora et al. 2026) DOI:: 10.1016/j.ijid.2026.108973 PMID:: 42425362 Study Design:: Single-center case–control proof-of-concept Sample Size:: n=12 Long-COVID-19 patients, n=8 controls (dyspeptic undergoing gastroscopy) Key Findings::
- Gastric mucosal biopsies (fundus + antrum), IHC with PGP 9.5 (pan-neuronal) and VIP (cholinergic), Neurolucida 360 3D nerve density quantification
- Significant reduction in mucosal innervation: fundus PGP 2.1 vs 3.9 nm/µm³ (p\<0.01), antrum 1.9 vs 3.9 (p\<0.05)
- VIP (cholinergic) loss more pronounced in fundus (p\<0.01), also antrum (p=0.01)
- IENF (leg skin biopsy) NOT different between groups → selective visceral autonomic involvement, sparing somatic fibres
- Nerve density correlated with HRV LF/HF (R=0.50, p\<0.05), NT-proBNP (R=0.52, p\<0.01), D-dimer (R=0.61, p\<0.01)
- Impaired HRV in LC: LF/HF 1.7±0.2 vs 1.1±0.1; rMSSD 15.3 vs 48.5; pNN50 0.8 vs 18.8; HF 3.8 vs 5.8 ln ms² (all p\<0.01)
- 66% orthostatic intolerance; higher D-dimer and NT-proBNPConclusion:: First in vivo morphological evidence of selective cholinergic denervation of gastric mucosa in Long COVID. Structural substrate for dysautonomia. Disruption of the cholinergic anti-inflammatory pathway (CAP) may sustain the proinflammatory state. Proposed mechanism: molecular mimicry against vagal nuclei (nucleus ambiguus, DMV). Therapeutic implications: VNS, cholinergic modulation. Limitations:: Small n; single center; controls were dyspeptic not healthy; no recovered-asymptomatic COVID group; cannot discriminate intrinsic enteric vs extrinsic vagal or cholinergic vs NANC VIP fibres. Certainty Assessment::
- *Quality:* Medium-High (IJID, novel IHC method, Neurolucida 360 quantification)
- *Sample:* Small (n=12+8)
- *Replication:* First such study — no direct replication yet; convergent with Woo 2023, Lladós 2024
- *Score:* 0.6014 Woo et al. 2023 — Vagus Nerve Inflammation in COVID-19
Full Citation:: Woo MS, Shafiq M, Fitzek A, et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathologica. 2023;146(3):387–394. (Woo et al. 2023) DOI:: 10.1007/s00401-023-02612-x PMID:: 37452829 PMCID:: PMC10412500 Study Design:: Postmortem histopathology + clinical cohort Sample Size:: Autopsy vagus nerves from COVID-19 patients and controls; clinical cohort n=323 Key Findings::
- SARS-CoV-2 RNA detected in postmortem vagus nerves
- Inflammatory cell infiltration composed primarily of monocytes
- RNA sequencing revealed strong inflammatory response in neurons, endothelial cells, and Schwann cells
- Inflammatory transcriptomic signature correlated with SARS-CoV-2 RNA load
- Clinical cohort: decreased respiratory rate in non-survivors of critical COVID-19, consistent with vagal dysfunctionConclusion:: SARS-CoV-2 induces vagus nerve inflammation followed by autonomic dysfunction. Provides direct anatomical evidence for vagal pathology as substrate for dysautonomia in acute and Long COVID. Limitations:: Postmortem — cannot assess functional changes; limited clinical phenotyping; acute COVID context not Long COVID per se. Certainty Assessment::
- *Quality:* High (Acta Neuropathologica, comprehensive histopathology+RNAseq)
- *Sample:* Adequate (autopsy + n=323 clinical)
- *Replication:* Convergent with Acanfora 2026 (structural denervation) and Lladós 2024 (ultrasound evidence)
- *Score:* 0.7515 Lladós et al. 2024 — Vagus Nerve Dysfunction in Post-COVID-19 Condition
Full Citation:: Lladós G, Massanella M, Coll-Fernández R, et al. Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study. Clinical Microbiology and Infection. 2024;30(4):515–521. (Lladós et al. 2024) DOI:: 10.1016/j.cmi.2023.11.007 PMID:: 37984511 Study Design:: Cross-sectional pilot with neck ultrasound Sample Size:: n=30 PCC (with vagal symptoms), n=14 recovered COVID, n=16 never-infected Key Findings::
- Vagus nerve thickening/hyperechogenicity on neck ultrasound in PCC: CSA 2.4±0.97 mm² vs 2.0±0.52 vs 1.9±0.73 (p=0.08)
- Reduced esophageal-gastric-intestinal peristalsis: 34% vs 0% vs 21% (p=0.02)
- Hemidiaphragm flattening: 47% vs 6% vs 14% (p=0.007)
- Maximal inspiratory pressure reduced: 62% vs 6% vs 17% (p≤0.001)
- Additional phrenic nerve involvementConclusion:: Vagus and phrenic nerve dysfunction contribute to PCC pathophysiology. Provides structural imaging evidence complementing Woo 2023 (histology) and Acanfora 2026 (mucosal denervation). Limitations:: Pilot sample size; cross-sectional; PCC group selected for vagal symptoms (referral bias); ultrasound operator-dependent. Certainty Assessment::
- *Quality:* Medium-High (CMI, controlled design, multi-modality assessment)
- *Sample:* Small-moderate (n=30 PCC)
- *Replication:* Convergent with Woo 2023 and Acanfora 2026
- *Score:* 0.6516 Tracey 2002 — The Inflammatory Reflex (CAP)
Full Citation:: Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853–859. (Tracey 2002) DOI:: 10.1038/nature01321 PMID:: 12490958 Study Design:: Foundational review Key Findings::
- Discovery that vagus nerve efferent signalling (the inflammatory reflex) inhibits pro-inflammatory cytokine release (TNF, IL-1, HMGB1)
- Efferent vagus nerve activates the cholinergic anti-inflammatory pathway (CAP) via alpha7 nicotinic acetylcholine receptor (α7nAChR) on tissue macrophages
- Neural circuits reflexively regulate immune responses in real time
- Pharmacological or electrical vagus nerve stimulation suppresses systemic inflammationConclusion:: The nervous system reflexively controls inflammation. The CAP provides the mechanistic link between vagal structural integrity and immune homeostasis. Directly relevant: structural vagal damage (Acanfora 2026) would disinhibit pro-inflammatory signalling. Limitations:: Review of foundational animal studies; human translation emerging at time of publication. Certainty Assessment::
- *Quality:* Very High (Nature, >3800 citations, foundational CAP paradigm)
- *Sample:* Review (N/A)
- *Replication:* Extensively replicated across species and by Bonaz, Pavlov, Olofsson groups
- *Score:* 0.8517 Bonaz et al. 2018 — Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
Full Citation:: Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Frontiers in Neuroscience. 2018;12:49. (Bonaz, Bazin, and Pellissier 2018) DOI:: 10.3389/fnins.2018.00049 PMID:: 29467611 PMCID:: PMC5808284 Study Design:: Comprehensive review Key Findings::
- Vagus nerve is 80% afferent, 20% efferent — bidirectional brain-gut communication
- Anti-inflammatory via HPA axis (afferent) and CAP (efferent, vagovagal)
- Vagal efferents synapse with enteric neurons → ACh release onto macrophages via α7nAChR → TNF inhibition
- Vagus also synapses with splenic sympathetic nerve → splenic anti-TNF pathway
- Bioelectronic medicine: VNS as non-pharmacological anti-TNF for IBDConclusion:: Comprehensive mechanistic review of vagal anti-inflammatory pathways. Establishes the theoretical framework linking structural vagal denervation (Acanfora 2026) to gastrointestinal and systemic inflammation via CAP disruption. Limitations:: Review (no new primary data); primarily derived from animal and IBD literature; ME/CFS-specific evidence limited. Certainty Assessment::
- *Quality:* High (Frontiers in Neuroscience, comprehensive, well-cited)
- *Sample:* Review (N/A)
- *Replication:* Convergent with Tracey 2002, Pavlov, Olofsson
- *Score:* 0.7018 VanElzakker 2013 — Vagus Nerve Infection Hypothesis of ME/CFS
Full Citation:: VanElzakker MB. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Medical Hypotheses. 2013;81(3):414–423. (Michael B. VanElzakker 2013) DOI:: 10.1016/j.mehy.2013.05.034 PMID:: 23790471 Study Design:: Hypothesis/theory paper Key Findings::
- Proposes ME/CFS results from infection of the vagus nerve (sensory ganglia/paraganglia)
- Pathogen-infected glial cells bombard sensory vagus with proinflammatory cytokines → exaggerated sickness behaviour
- Explains: fatigue, myalgia, depression, cognitive dysfunction, fever
- Any pathogen infecting vagus nerve can cause ME/CFS — resolves single-pathogen controversy
- Predicts vagal ganglia inflammation as testable mechanismConclusion:: Predictive hypothesis that anticipated Woo 2023 (vagus nerve inflammation in COVID-19) and Acanfora 2026 (structural vagal denervation in Long COVID) by a decade. Directly proposes vagal pathology as ME/CFS substrate. Highly prescient and falsifiable framework. Limitations:: Hypothesis only — no primary data; published in Medical Hypotheses (lower-tier journal); no direct experimental confirmation until Woo 2023. Certainty Assessment::
- *Quality:* Low-Medium (hypothesis paper, Medical Hypotheses)
- *Sample:* N/A (theoretical)
- *Replication:* Partially validated by Woo 2023, Lladós 2024, Acanfora 2026
- *Score:* 0.4019 Oaklander (Joseph) et al. 2021 — PGP 9.5 Skin Biopsy SFN in ME/CFS (iCPET)
Full Citation:: Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, Systrom DM. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160(2):642–651. (Joseph et al. 2021) DOI:: 10.1016/j.chest.2021.01.082 PMID:: 33577778 PMCID:: PMC8727854 Study Design:: Large retrospective with iCPET + skin biopsy Sample Size:: n=160 ME/CFS meeting criteria, n=36 controls Key Findings::
- PGP 9.5-immunolabeled lower-leg skin biopsies (same PGP 9.5 marker as Acanfora 2026)
- 31% of ME/CFS biopsies consistent with SFN (epidermal innervation below the 5th percentile of predicted; p\<0.0001)
- iCPET identified two neurovascular dysregulation types: (1) depressed Qc from impaired venous return, (2) impaired peripheral O2 extraction
- SFN-associated oxygen shunting hypothesis: microvascular dilation shunts oxygenated blood from capillary beds
- Denervation severity did NOT correlate with exertional measuresConclusion:: Establishes PGP 9.5 IHC skin biopsy as method for SFN detection in ME/CFS (same method as Acanfora 2026 used on gastric mucosa, not skin). Key contrast: Acanfora found NO skin denervation in Long COVID, suggesting selective visceral vagal involvement distinct from the somatic SFN in ME/CFS. Limitations:: Retrospective; referral bias (tertiary centre); skin biopsy only (lower leg) — cannot assess visceral nerve density. Certainty Assessment::
- *Quality:* High (Chest journal, large-n, objective iCPET+biopsy)
- *Sample:* Large (n=160 ME/CFS)
- *Replication:* Oaklander group replicated SFN in ME/CFS across multiple cohorts
- *Score:* 0.7020 Auditory and Sensory Dysfunction
Full Citation:: Johnson SK, DeLuca J, Diamond BJ, Natelson BH. Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls. Perceptual and Motor Skills. 1996;83(1):51–62. DOI:: 10.2466/pms.1996.83.1.51 PMID:: 8873173 Key Findings:: Landmark study demonstrating modality-specific cognitive impairment in ME/CFS. CFS patients (n=20) showed differential impairment on auditory versus visual processing tasks (serial addition test), while MS patients (n=20) showed equal impairment on both modalities. Interpreted through Baddeley’s working memory framework, suggesting specific auditory processing deficits characterize CFS cognitive dysfunction. Relevance:: First controlled evidence of selective auditory processing impairment in ME/CFS. Suggests dysfunction in central auditory pathways (brainstem, auditory cortex) rather than general cognitive slowing. Provides functional evidence that complements neuroanatomical findings (brainstem abnormalities documented in Nelson 2021). Certainty:: Medium-High (controlled study with active disease comparator [MS], validated cognitive testing paradigm; moderate sample size n=20 per group).
Full Citation:: Schubert NMA, Rosmalen JGM, van Dijk P, Pyott SJ. A retrospective cross-sectional study on tinnitus prevalence and disease associations in the Dutch population-based cohort Lifelines. Hearing Research. 2021;411:108355. DOI:: 10.1016/j.heares.2021.108355 PMID:: 34607212 Key Findings:: First large-scale population-based study (n=124,609) demonstrating significant association between chronic fatigue syndrome and constant tinnitus (OR 1.568, approximately 57% increased odds). Among 6.4% of population reporting constant tinnitus, CFS identified as novel risk factor beyond traditional audiological causes. Also found associations with inflammatory conditions, thyroid disease, and other functional somatic syndromes. Relevance:: Provides robust epidemiological evidence linking ME/CFS to auditory symptoms at population scale. Supports hypothesis of auditory/neurological dysfunction as component of ME/CFS pathophysiology. Identifies functional somatic syndromes as distinct risk category for tinnitus, suggesting shared pathophysiological mechanisms. Tinnitus screening may be clinically warranted in ME/CFS patients. Certainty:: High (exceptionally large sample n=124,609, population-based cohort, peer-reviewed in Hearing Research; limitation: cross-sectional design cannot establish causality; self-reported CFS diagnosis not clinically verified).
Full Citation:: Skare TL, de Carvalho JF, de Medeiros IRT, Shoenfeld Y. Ear abnormalities in chronic fatigue syndrome (CFS), fibromyalgia (FM), Coronavirus-19 infectious disease (COVID) and long-COVID syndrome (PCS), sick-building syndrome (SBS), post-orthostatic tachycardia syndrome (PoTS), and autoimmune/inflammatory syndrome induced by adjuvants (ASIA): A systematic review. Autoimmunity Reviews. 2024;23(10):103606. DOI:: 10.1016/j.autrev.2024.103606 PMID:: 39209013 Key Findings:: Comprehensive systematic review of 172 articles (1990–2024) examining hearing and vestibular disturbances across ME/CFS and related post-infectious/autoimmune conditions. Cochlear complaints (tinnitus, hearing loss, hyperacusis) identified as most frequent across all conditions. Vestibular symptoms less common but documented. Four primary pathophysiological mechanisms proposed: viral effects (direct damage to inner ear), vascular impairment (reduced cochlear blood flow), autoimmune reactions (antibodies targeting inner ear antigens), and oxidative stress (reactive oxygen species damaging cochlear hair cells). Relevance:: Establishes ear abnormalities as well-documented feature across ME/CFS, fibromyalgia, long-COVID, and PoTS, suggesting shared pathophysiological mechanisms among post-infectious syndromes. Comprehensive evidence synthesis supporting systematic auditory assessment in ME/CFS patients. Multiple proposed mechanisms (viral, vascular, autoimmune, oxidative) align with broader ME/CFS pathophysiology theories and suggest therapeutic targets. Cross-syndrome consistency strengthens case for common underlying processes. Certainty:: High (systematic review of 172 articles in Autoimmunity Reviews, extensive literature synthesis; limitations: heterogeneous study quality across reviewed articles, primarily descriptive synthesis without meta-analysis, mechanisms largely hypothetical pending experimental validation).
21 Craniocervical Instability and Structural Abnormalities
Full Citation:: Bragée B, Michos A, Drum B, et al. Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Neurology. 2020;11:828. DOI:: 10.3389/fneur.2020.00828 PMID:: 32982905 Key Findings:: First large-scale structural imaging study in ME/CFS (n=229) using upright MRI. Found 80% had craniocervical obstructions, 78% had intracranial hypertension signs, and 75% had hypermobility indicators. Notably, 45% had Chiari malformation (vs. 0.5–1% in general population). Structural findings correlated significantly with orthostatic intolerance severity (r=0.42, p<0.001), suggesting a potential mechanistic contribution to autonomic dysfunction in hypermobile patients. Relevance:: Establishes high prevalence of structural abnormalities in ME/CFS, particularly in hypermobile subset. Upright imaging critical—supine MRI misses many findings. However, study from specialized clinic (Bragée Clinics) that focuses on structural interventions; independent replication in community-based cohorts needed to determine generalizability. Certainty:: Medium (large prospective sample, but single specialized center with potential selection bias; pending replication).
Full Citation:: Lohkamp L-N, Marathe N, Fehlings MG. Craniocervical Instability in Ehlers-Danlos Syndrome—A Systematic Review of Diagnostic and Surgical Treatment Criteria. Global Spine Journal. 2022;12:1862–1871. DOI:: 10.1177/21925682211068520 Key Findings:: Systematic review of 16 studies (695 EDS patients) examining CCI diagnostic criteria and surgical outcomes. Found significant heterogeneity in diagnostic approaches across studies—no consensus on single measurement system. Dynamic upright MRI superior to supine static imaging. Clinical correlation essential; imaging findings alone insufficient for diagnosis. Relevance:: Provides context for CCI diagnosis in hypermobile ME/CFS subset (estimated 20–40% of ME/CFS have hypermobile EDS or joint hypermobility). Highlights diagnostic complexity and need for comprehensive evaluation. Certainty:: Medium-High (systematic review of 16 studies, but high heterogeneity between studies limits ability to establish unified criteria).
Full Citation:: Nicholson P, Mulcahy D, Gormley G, et al. Reference values of four measures of craniocervical stability using upright dynamic magnetic resonance imaging. Clinical Anatomy. 2023;36(5):740–747. DOI:: 10.1002/ca.24014 PMID:: 36929156 Key Findings:: Established updated reference ranges for CCI measurements using upright dynamic MRI in 50 healthy adults. Previous thresholds from supine imaging may be overly strict. Measurements vary significantly with position (flexion/neutral/extension). Relevance:: Provides evidence-based thresholds for interpreting CCI measurements in patient populations. Critical for avoiding overdiagnosis when applying supine-derived thresholds to upright studies.
Full Citation:: Henderson FC, Francomano CA, Koby M, et al. Craniocervical instability in patients with Ehlers-Danlos syndromes: outcomes analysis following occipito-cervical fusion. Neurosurgical Review. 2024;47(1):27. DOI:: 10.1007/s10143-023-02249-0 PMID:: 38163828 Key Findings:: Retrospective analysis of 53 EDS patients undergoing occipito-cervical fusion for CCI. At mean 18-month follow-up: 71% showed pain improvement (VAS 7.8→3.2), 68% functional improvement (NDI 58%→28%), 65% neurological improvement. Complication rate 19% (mainly hardware-related), reoperation rate 11%. Relevance:: Demonstrates surgical intervention can be effective for properly selected patients, but complication rates are significant. Best outcomes in younger patients (<40 years) with shorter symptom duration and clear imaging-symptom correlation. Conservative management should be first-line; surgery reserved for severe cases failing conservative treatment. Certainty:: Medium (retrospective, single center, no control group; but validated outcome measures and adequate follow-up).
Full Citation:: Russek LN, Block NV, Byrne E, et al. Presentation and physical therapy management of upper cervical instability in patients with symptomatic generalized joint hypermobility: International expert consensus recommendations. Frontiers in Medicine. 2023;9:1072764. DOI:: 10.3389/fmed.2022.1072764 PMID:: 36743674 Key Findings:: International expert consensus (18 experts) on conservative management of upper cervical instability in hypermobile patients. Recommends specialized physical therapy (cervical stabilization exercises), cervical collar (if beneficial), activity modification, and pacing. Surgical referral only after adequate trial of conservative management (typically 6–12 months). Relevance:: Provides evidence-based conservative treatment protocol for ME/CFS patients with hypermobility and suspected CCI. First-line approach before considering surgical intervention.
Full Citation:: Klinge PM, Srivastava V, McElroy A, et al. Abnormal spinal cord motion at the craniocervical junction in hypermobile Ehlers-Danlos patients. Journal of Neurosurgery: Spine. 2021;35(6):740–746. DOI:: 10.3171/2021.3.SPINE21106 PMID:: 34020423 Key Findings:: Demonstrates abnormal spinal cord motion disorder at the craniocervical junction in hypermobile EDS patients using dynamic MRI. Explains why static imaging may miss dynamic pathology.
Full Citation:: Milhorat TH, Bolognese PA, Nishikawa M, et al. Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and Chiari malformation type I in patients with hereditary disorders of connective tissue. Journal of Neurosurgery: Spine. 2007;7:601–609. DOI:: 10.3171/SPI-07/12/601 PMID:: 18074684 Key Findings:: Seminal paper establishing the connection between hereditary connective tissue disorders (including EDS), Chiari malformation, and craniocervical instability. Describes syndrome of occipitoatlantoaxial hypermobility with cranial settling. Relevance:: Foundational work establishing EDS-Chiari-CCI triad. Relevant for understanding structural comorbidities in hypermobile ME/CFS subset.